Preferences of adults with cancer for systemic cancer treatment: do preferences differ based on age?

Prajwal Dhakal, Christopher S. Wichman, Bunny Pozehl, Meaghann Weaver, Alfred L. Fisher, Julie Vose, R. Gregory Bociek, Vijaya R. Bhatt

    Resultado de la investigación: Articlerevisión exhaustiva

    7 Citas (Scopus)

    Resumen

    Background: We used the Therapy Preference Scale, a 30-item questionnaire, to determine cancer treatment preferences of adults with cancer. Methods: We used Wilcoxon's rank sum test and Fisher's exact test to compare the preferences of younger (<60 years) versus older adults (≥60 years). Results: While 56% of patients would accept treatment offering increased life expectancy at an expense of short-term side effects, 75% preferred maintenance of cognition, functional ability and quality of life to quantity of days. Oral instead of intravenous treatment (p = 0.003), shorter hospital stay (p = 0.03), preservation of cognitive function (p = 0.01) and avoidance of pain (p = 0.02) were more important to older patients compared with younger patients. Conclusion: Many patients prioritized maintenance of cognition, functional ability and quality of life; older patients valued oral treatment, shorter hospital stay, preservation of cognitive function and avoidance of pain.

    Idioma originalEnglish (US)
    Páginas (desde-hasta)311-321
    Número de páginas11
    PublicaciónFuture Oncology
    Volumen18
    N.º3
    DOI
    EstadoPublished - ene 2022

    ASJC Scopus subject areas

    • Oncology
    • Cancer Research

    Huella

    Profundice en los temas de investigación de 'Preferences of adults with cancer for systemic cancer treatment: do preferences differ based on age?'. En conjunto forman una huella única.

    Citar esto